Tuesday, July 2, 2024 NIAID Scientists Find New Role of Pathway in Antifungal Immunity Aspergillus fumigatus, a fungus that can cause infections in people called Aspergillosis. Credit: CDC NIAID scientists learned why some people receiving cancer treatments called Bruton's tyrosine kinase (BTK) inhibitors develop infections caused by Aspergillus fungi. The BTK pathway, which is blocked by the treatment, plays a crucial role in providing antifungal immunity. The scientists say this finding may lead to improved care for people receiving BTK inhibitors. The findings were published in the Journal of Clinical Investigation. Learn More National Institute of Allergy and Infectious Diseases  |  National Institutes of Health

---

Update your subscriptions, modify your password or e-mail address, or stop subscriptions at any time on your Subscriber Preferences Page. You will need to use your e-mail address to log in. If you have questions or problems with the subscription service, please contact Subscriber Help. Your subscription may be removed if you do not open our emails for a six-month period. 

This service is provided to you at no charge by National Institute of Allergy and Infectious Diseases (NIAID).

                           

---

This email was sent to myhcistech.healthnews360@blogger.com using GovDelivery Communications Cloud on behalf of: National Institute of Allergy and Infectious Diseases · 5601 Fishers Lane · Bethesda, MD 20892 · 1-866-284-4107